Skip to content
healthcare.dev
Get a free key

CALQUENCE

NDC 0310-0512, Acalabrutinib, capsule, gelatin coated, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-0512
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210259
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0512 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACALABRUTINIB100 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Tyrosine Kinase Inhibitors [MoA]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dd4835ef-e1bc-4997-a399-1ffa2556fbfe

Use it

Look up 0310-0512 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0512 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-0512. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.